Superworth

Coya Therapeutics EPS COYA

Diluted earnings per share by quarter and over the last twelve months, from 2022.

Last 12 months, to Jun 30, 2026
−$1.07
Latest quarter, Q2 FY26
−$0.28
Fiscal year 2025
−$1.27

Coya Therapeutics' earnings per share was −$1.07 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.28.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.27n/a
FY2024−$0.98n/a
FY2023−$0.82n/a
FY2022−$4.73n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.28n/a−$1.07
Q1 FY26−$0.32n/a−$1.15
Q4 FY25−$0.34n/a−$1.27
Q3 FY25−$0.13n/a−$1.11
Q2 FY25−$0.36n/a−$1.24
Q1 FY25−$0.44n/a−$1.07
Q4 FY24−$0.18−264%−$0.98
Q3 FY24−$0.26n/a−$0.69
Q2 FY24−$0.19n/a−$0.77
Q1 FY24−$0.35n/a−$0.89
Q4 FY23$0.11n/a−$0.82
Q3 FY23−$0.34n/a−$2.13

Against its peers

Companies in Drug Manufacturers - General nearest Coya Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
COYACoya Therapeutics−$1.07
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Coya Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.